Viewing nowCombinationDunab Tablet 60/2.5 mg (Pimasartan Potassium, Amlodipine)
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Korea Hutech Pharm Co., Ltd.

MFDS item code 202204667 · Approved 2022.12.27 · Insurance code 649105680
Treatment of essential hypertension not controlled with fimasartan monotherapy
Pimasartan potassium is used for patients with essential hypertension and may require additional treatment if blood pressure is not adequately controlled with monotherapy. This medication lowers blood pressure and relieves the burden on the heart and blood vessels. It acts as an adjunctive treatment when blood pressure management is not sufficient. It contributes to safe and effective blood pressure control, assisting in the overall blood pressure management of patients. It is used for the treatment of essential hypertension.
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; discontinue immediately if pregnancy is confirmed. Patients with allergies to the ingredients in this medication, those who are pregnant or breastfeeding, patients undergoing renal dialysis, patients with moderate to severe liver dysfunction, patients with bile duct obstruction, and those with certain kidney dysfunctions or diabetic nephropathy should not take this medication. Patients with reduced blood volume or low sodium, patients with impaired kidney function, renal artery hypertension, aortic stenosis, severe hypotension, and elderly patients should use this medication with caution. While taking this medication, side effects such as dizziness, headache, facial or peripheral edema, urinary disorders, insomnia, and flushing may occur, and one should consult a doctor if symptoms are severe. Symptoms of hypotension or electrolyte imbalance, especially hyperkalemia, may occur, so regular blood tests are important. Drowsiness or dizziness may occur while taking this medication, so caution should be exercised when driving or operating dangerous machinery. Interactions may occur if taken with other antihypertensives or diuretics, potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs, so it is essential to consult with a doctor or pharmacist. Pregnant or breastfeeding women should consult with healthcare professionals before taking this medication, particularly during pregnancy where avoidance is safest. It is not recommended for children under 18 years old as the safety and effectiveness of this medication have not been established in this age group. In case of overdose, symptoms such as severe hypotension or arrhythmias may occur, and immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, to maintain the medication's efficacy, it should be stored at a temperature between 1°C and 30°C.
Yellow, round-edged, rectangular film-coated tablet
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Korea Hutech Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.